Articles related to PRODUCT RECALL

The recent recall of Zenzedi 30 mg tablets due to contamination stresses the importance of meticulous medication management and awareness of the broader challenges in ADHD treatment availability and safety.

In light of the voluntary recall of Neptune’s Fix due to its dangerous ingredient, tianeptine, healthcare professionals should be vigilant in advising patients against the use of unregulated supplements and emphasize the importance of FDA-approved treatments.

Stay informed about recent recalls to ensure patient safety. Learn more about the recall of a blood pressure medication contaminated with oxycodone.

Takeda’s decision to withdraw Exkivity from the US market raises questions about treatment alternatives for NSCLC patients with specific EGFR mutations; stay updated on this evolving situation.

Unprecedented eye drop recalls have led to significant health risks, including four fatalities. Learn more to ensure that you guide your patients towards safer, FDA-approved alternatives.

Marlex Pharmaceuticals has initiated a critical recall of specific lots of Digoxin Tablets due to a labeling error. Physicians are urged to exercise extreme caution and verify their inventory to prevent adverse patient outcomes.